NCT06848309View on ClinicalTrials.gov

Dissecting Human Immune Responses to Infection with Influenza or SARS-CoV-2

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

March 7, 2025

Primary Completion Date

April 30, 2029

Study Completion Date

October 31, 2029

Conditions
InfluenzaSARS-CoV-2 (COVID-19) InfectionImmune Response of Host
Interventions
PROCEDURE

Bronchoscopy

Some participants in all 5 groups may undergo an optional bronchoscopy procedure with bronchoalveolar lavage and endobronchial biopsy collection if they choose.

Trial Locations (1)

63110

RECRUITING

Washington University in Saint Louis Department of Emergency Medicine, Emergency Care Research Core, St Louis

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Washington University School of Medicine

OTHER